By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genicon Sciences Corporation (Now part of Invitrogen) 

Press release archived for reference only.

Carlsbad  California  92008  U.S.A.
Phone: n/a Fax: n/a


Genicon Sciences has developed an ultra-sensitive signal generation and detection system that utilizes resonance light scattering technology - RLS Technologyâ„¢ - to meet the needs of scientist and companies working on microarrays, biochips, genomics, proteomics, combinatorial chemistry, and high throughput screening (HTS).

Genicon Sciences is focused on three distinct market segments - research (drug discovery and research), drug development (clinical trials- Phase I, II, III, IV) and treatment-linked diagnostics (FDA approved products). Key customers include: university/academic researchers, pharma and biopharmaceutical companies, genomic and pharmacogenomic companies, bioanalytical instrumentation and biochip manufacturers, clinical diagnostic manufacturers, clinical research organizations (CROs) and reference laboratories.

The company has a comprehensive yet diversified marketing strategy that allows "open access" to its technology and products, which will enable emerging genomic, pharmacogenomic and proteomic businesses as well as facilitate the development of new treatment-linked diagnostics.

Strategic Relationships

Genicon Sciences will provide both individual researchers and commercial entities that use microarrays, biochips (or microfluidics), and micro and nano-well assay test systems with "open access" to its RLS Technology and products. Genicon Sciences has targeted developers of existing applications as well as those creating next generation technologies. Genicon Sciences has adopted a channel distribution and value added re-seller (VAR) business model that has proven successful in the high-tech and cable television industries to establish its RLS Technology "brand" and garner widespread market penetration quickly and efficiently.

last update 8-30-01

Key Statistics

Ownership: Subsidiary

Web Site: Genicon Sciences Corporation



Collins Development Company 

Company News
Currently No News Articles